A. Mark Fendrick, MD

In conjunction with provider-oriented payment reform, tools like VBID that change the focus from how much to how well we spend our healthcare dollars.

This commentary discusses why antibiotics and the treatment of infectious diseases present a special case for pharmaceutical development, pricing, and appropriate utilization.

Cliff Goodman, PhD, moderated a panel discussion on the Implications of Healthcare Reform: 'No' Will Be Heard.

Implications of Healthcare Reform: 'No' Will Be Heard is led by Cliff Goodman, PhD, in a panel discussion featuring A. Mark Fendrick, MD, co-editor in chief of The American Journal of Managed Care, John L. Fox, MD, MHA, and Ira M. Klein, MD, MBA, FACP. The panelists determine what it means when a patient says no.

Mark Fendrick, MD, co-editor-in-chief of The American Journal of Managed Care, concludes the PCDC event with his closing remarks.

Formularies of the future should use evidence-produced CER to better target, not limit, diabetes care.

We describe how shifting focus from those visiting the ED to those admitted to the hospital from the ED offers more potential for improving healthcare efficiency.

Journal of Oncology Practice (JOP) and The American Journal of Managed Care (AJMC) join efforts to highlight work focusing on issues affecting payers and providers.

Insights Into Value-Based Insurance Design in Oncology

The editors introduce this special issue, which contributes to an ongoing dialogue in cancer care that explores the tension between new therapeutics and the ever-increasing need to limit resources.

Dr. A Mark Fendrick welcomes the participants to the Healthcare Innovations and HIT Q&A Session at the National Press Club.

In this commentary, our Co-Editors-in-Chief advocate valuebased principles that align incentives to encourage use of high value services as an important tool in healthcare reform.

Dr. A. Mark Fendrick explains the concept of Value-Based Insurance Design (VBID) and how it works.